Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts

Clinical and Experimental Immunology

Volumn 115, Issue 3, 1999, Pages 443-450

  Messele, Tsehaynesh ^b   Abdulkadir, M ^c   Fontanet, A L ^c   Petros, B ^a   Hamann, D ^c   Koot, M ^c   Roos, M T L ^c   Schellekens, P T A ^c   Miedema, F ^c   Rinke De Wit, T F ^c  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

^b ETHIOPIAN PUBLIC HEALTH INSTITUTE   (Ethiopia)

^c NONE

Author keywords

Activation; Ethiopia; HIV 1; Naive cells; T cells

Indexed keywords

CD28 ANTIGEN;

ADULT; AGED; AIDS RELATED COMPLEX; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHIOPIA; ETHNIC DIFFERENCE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNE STATUS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; NETHERLANDS; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; ETHIOPIA; FEMALE; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; NETHERLANDS; T-LYMPHOCYTE SUBSETS;

EID: 0013109560     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00815.x     Document Type: Article

References (44)

1. Roederer M. T-cell dynamics of immunodeficiency. Nature Medicine 1995; 1:621-2.
2. Giorgi JV, Detels R. T-cell subset alterations in HIV-infected homosexual men. NIAID Multicenter AIDS Cohort Study. Clin Immunol Immunopathol 1989; 52:10-18.
3. Roederer M, Herzenberg LA, Herzenberg LA. Changes in antigen densities on leukocyte subsets correlate with progression of HIV disease, Int Immunol 1995; 8:1-11.
4. Margolick JB, Donnenberg AD, Munoz A, Park LP, Bauer KD, Giorgi JV, Ferbas J, Saah AJ. Changes in T- and non-T lymphocyte subsets following seroconversion to HIV-1: stable CD3+ and declining CD3- populations suggest regulatory responses linked to loss of CD4 lymphocytes. The Multicenter AIDS Cohort Study. J AIDS 1993; 6:153-61.
5. Roos MT, Leeuw NASM, Claessen FAP et al. Viro-immunological studies in acute HIV-1 infection. AIDS 1994; 8:1533-8.
6. Polk BF, Fox R, Brookmeyer R et al. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Mod 1987; 316:61-66.
7. De Wolf F, Lange JMA, Houweling JTM et al. Numbers of CD4+ T-cells and the levels of core antigens and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men. J Infect Dis 1988; 158:615-22.
8. Fahey JL, Taylor JM, Detels R, Hofmann B, Melmed R, Nishanian P, Giorgi JV. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 1990; 322:166-72.
9. Roederer M, Gregson Dubs J, Anderson MT, Raju PA, Herzenberg LA, Herzenberg LA. CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest 1995; 95:2061-6.
10. Rabin RL, Roederer M, Maldonado Y, Petru A, Herzenberg LA, Herzenberg LA. Altered representation of naive and memory CD8 T cell subsets in HIV infected children. J Clin Invest 1995; 95:2054-60.
11. Prince HE, Jensen ER. Three-color cytofluorometric analysis of CD8 cell subsets in HIV-1 infection. J AIDS 1991; 4:1227-32.
12. Autran B, Giorgi JV. Activated CD8+ cells in HIV-related diseases. In: Janossy G, Autran B, Miedema F, eds. Immunodeficiency in HIV infection and AIDS. Basel: Karger, 1992:171-84.
13. Ho HN, Hultin LE, Mitsuyasu RT et al.. Circulating HIV specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens. J immunol 1993; 150:3070-9.
14. Giorgi JV, Ho HN, Hirji K et al. CD8+ lymphocyte activation at human immunodeficiency virus type 1 serconversion. Development of HLA- DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. J Infect Dis 1994; 170:775-81.
15. Kestens L, Vanham G, Vereecken C, Vandenbruaene M, Vercauteren G, Colebunders RL, Gigase P. Selective increase of activation antigens HLA-DR and CD38 on CD4+CD45RO+ T lymphocytes during HIV-1 infection. Clin Exp Immunol 1994; 95:436-41.
16. Ramzaoui S, Jouen-Beades F, Gilbert D, Borsa-Lebas F, Michel Y, Humbert G, Tron F. During HIV infection CD4+CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+CD38- T-cells. Clin Immunol Immunopathol 1995; 77:33-41.
17. The status and trends of the HIV/AIDS epidemics in sub-Saharan Africa 1997-98. Report of the MAP net work symposium. 3-4 Dec 1997, Abidijan, Cote d'Ivoire.
18. Todd J, Balira R, Grosskurth H et al. HIV-associated adult mortality in a rural Tanzanian population. AIDS 1997; 11:801-7.
19. Anzala OA, Nagelkerke NJ, Bwayo JJ, Holton D, Moses S, Ngugi EN, Ndinya-Achola JO, Plummer FA. Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection. J Infect Dis 1995; 171:686-9.
20. Bentwich Z, Kalinkovich A, Weisman Z. Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today 1995; 16:187-91.
21. Rizzardini G, Piconi S, Ruzzante S et al. Immunological activation markers in the serum of African and European HIV-seropositive and seronegative individuals. AIDS 1996; 10:1535-42.
22. Weissman D, Barker TD, Fauci AS. The efficiency of acute infection of CD4+ T cells is markedly enhanced in the setting of antigen-specific immune activation. J Exp Med 1996; 183:687-92.
23. Semba RD, Graham NM, Caiaffa WT, Margolick JB, Clement L, Vlahov D. Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection. Arch Int Mod 1993; 153:2149-54.
24. Actor JK, Shirai M, Kullberg MC, Buller RM, Sher A, Berzofsky JA. Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th 1 cytokine responses as well as delayed virus clearance. Proc Natl Acad Sci USA 1993; 90:948-52.
25. World Health Organization. Weekly epidemiological record. 1990; 29:221-4.
26. Hamann D, Baars PA, Rep MHG, Hooibrink B, Kerkhof-Garde SR, Klein MR, Van Lier RA. Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med 1997; 186:1407-18.
27. Yazdanbakhsh M, Sartono E, Kruize YC et al. Elevated levels of T cell activation antigen CD27 and increased interleukin-4 production in human lymphatic filariasis. Eur J Immunol 1993; 23:3312-7.
28. Elson LH, Shaw S, van Lier RA, Nutman TB. T cell subpopulation phenotypes in filarial infections: CD27 negativity defines a population greatly enriched for Th2 cells. Int Immunol 1994; 6:1003-9.
29. Sanders ME, Makgoba MW, Shaw S. Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsets. Immunol Today 1988; 9:195-9.
30. Worku S, Christensson B, Bjorkman A, Islam D. Higher proportion of CD8+ T cells in the blood in healthy adults from Ethiopia and Bangladesh compared with Sweden. Trans Roy Soc Trop Mod Hyg 1997; 91:618-22.
31. De Jong R, Brouwer M, Hooibrink B, Van der Pouw Kraan T, Miedema F, Van Lier RA. The CD27 subset of peripheral blood memory CD4+ lymphocytes contains functionally differentiated T lymphocytes that develop by persistent antigenic stimulation in vivo. Eur J Immunol 1992; 22:993-9.
32. Baars PA, Maurice MM, Rep M, Hooibrink B, Van Lier RA. Heterogeneity of the circulating human CD4+ T cell population. Further evidence that the CD4+CD45RA-CD27- T cell subset contains specialized primed T cells. J Immunol 1995; 154:17-25.
33. Linsley PS, Clark EA, Ledbetter JA. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc Natl Acad Sci USA 1990; 87:5031-5.
34. Vingerhoets JH, Vanham GL, Kestens LL et al. Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV infected subjects. Clin Exp Immunol 1995; 100:425-33.
35. Azuma M, Phillips JH, Lanier LL. CD28- T lymphocytes. Antigenic and functional properties. J Immunol 1993; 150:1147-59.
36. Borthwick NJ, Bofill M, Gombert WM et al. Lymphocyte activation in HIV-1 infection, II. Functional defects of CD28- T cells. AIDS 1994; 8:431-41.
37. Brinchmann JE, Dobloug JH, Heger BH, Haaheim M, Sannes M, Egeland T. Expression of costimulatory molecule, CD28 on T cells in human immunodeficiency virus type 1 infection. Functional and clinical correlations. J Infect Dis 1994; 169:730-8.
38. Monteiro J, Batliwalla F, Ostrer H, Gregersen PK. Shortened telomers in clonally expanded CD28-CD8+ T cells imply a replicative history that is distinct from their CD28+CD8+ counterparts. J Immunol 1996; 156:3587-90.
39. Effros RB, Allsopp R, Chiu C-P et al. Shortened telomers in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS 1996; 10:F17-F22.
40. Bleul CC, Wu L, Hoxie JA, Springer TA, Mackay CR. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci USA 1997; 94:1925-30.
41. Rubbert A, Weissman D, Combadiere C, Pettrone KA, Daucher JA, Murphy PM, Fauci AS. Multifactorial nature of noncytolytic CD8+ T cell-mediated suppression of HIV replication: beta-chemokine-dependent and -independent effects. AIDS Res Hum Retrovir 1997; 13:63-69.
42. Vingerhoets J, Kestens L, Penne G et al. CD8+ cells and not CD4+ T- cells are hyporesponsive to CD28 and CD40L-mediated activation in HIV-infected subjects. Clin Exp Immunol 1997; 107:440-7.
43. Reinherz EL, Kung PC, Goldstein G, Levey RH, Schlossman SF. Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc Natl Acad Sci USA 1980; 77:1588-92.
44. Salazar-Gonzalez JF, Moody DJ, Giorgi JV, Martinez-Maza O, Mitsuyasu RT, Fahey JL. Reduced ecto-5′-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CD8 (T-suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: evidence of CD8 cell immaturity. J Immunol 1985; 135:1778-85.